Australia markets open in 7 hours 25 minutes

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.77-0.21 (-1.05%)
At close: 04:00PM EDT
19.80 +0.03 (+0.15%)
After hours: 07:56PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
625,448
618,727
516,409
490,490
298,845
Cost of revenue
221,611
209,414
120,386
74,091
58,468
Gross profit
403,837
409,313
396,023
416,399
240,377
Operating expenses
Research development
332,852
331,312
265,667
211,752
570,923
Selling general and administrative
345,824
343,330
298,300
257,560
202,326
Total operating expenses
678,676
674,642
563,967
469,312
773,249
Operating income or loss
-274,839
-265,329
-167,944
-52,913
-532,872
Interest expense
15
33
476
866
1,682
Total other income/expenses net
169
-307
-198
-142
-1,454
Income before tax
-256,912
-248,763
-161,971
-53,715
-534,476
Income tax expense
7,389
6,336
4,029
4,508
8,255
Income from continuing operations
-264,301
-255,099
-166,000
-58,223
-542,731
Net income
-264,301
-255,099
-166,000
-58,223
-542,731
Net income available to common shareholders
-264,301
-255,099
-166,000
-58,223
-542,731
Basic EPS
-1.46
-2.18
-1.46
-0.53
-5.37
Diluted EPS
-1.46
-2.18
-1.46
-0.53
-5.37
Basic average shares
113,859
117,165
113,859
110,348
101,152
Diluted average shares
113,859
117,165
113,859
110,348
101,152